Related Experiment Video
Updated: May 3, 2026

Real-Time Monitoring of Neurocritical Patients with Diffuse Optical Spectroscopies
Published on: November 19, 2020
Neurovascular coupling assessment by transcranial doppler in acute stroke could be informative of long-term cognitive
Juliana Ferreira1, Frederica Alves2, Tiago Pedro3
1Department of Clinical Neurosciences and Mental Health, UnIC@RISE, Faculty of Medicine of the University of Porto, Porto, Portugal.
Abstract:
To assess whether Neurovascular Coupling (NVC) status in acute ischemic stroke predicts long-term cognitive impairment, this prospective study included consecutive ischemic stroke patients, without prior cognitive deficits, recruited between September 2021 and August 2022. Transcranial Doppler (TCD) monitoring was performed within 72 hours post-stroke to measure NVC, determined by peak relative increase in cerebral blood velocity (CBv) in the posterior cerebral artery (PCA) during a visual stimulus. Age-, gender-, and vascular risk factor-matched controls were included. The primary outcome was cognitive status at 12 months, evaluated using a 7-point cognitive scale. A total of 144 acute stroke patients and 40 controls were included. NVC exhibited a U-shaped association with long-term cognitive outcomes. Patients in both the lowest (CI95% 2.29 [1.23-4.28], p < 0.01) and highest (CI95% 0.53 [0.29-0.98], p = 0.04) quintiles of NVC magnitude had significantly worse cognitive scores at 12 months compared to those in the reference quintile. NVC assessment via TCD in the acute phase of ischemic stroke may serve as a predictor of long-term cognitive impairment, suggesting that both diminished and exaggerated NVC responses are linked to poorer cognitive outcomes.
More Related Videos
Related Concept Videos
Measurement of Blood Pressure
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Hemorrhagic Stroke l: Introduction
Hemorrhagic Stroke ll: Pathophysiology
Cerebral Edema ll: Pathophysiology

